Selective PPARα Modulator Pemafibrate Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through Regulation of Leptin Signaling and Remodeling of Gut Microbiota.
- DOI
- 10.3390/ijms27177611
- Published
- 2026-08-25
- Container
- Int J Mol Sci
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijms27177611,
title = {Selective PPARα Modulator Pemafibrate Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through Regulation of Leptin Signaling and Remodeling of Gut Microbiota.},
author = {Yamamoto K and Baba M and Kubo A and Yamada R and Nakamura A and Morikawa K and Ohara M and Nakai M and Sho T and Suda G and Ogawa K and Furuya K and Sakamoto N.},
year = {2026},
journal = {Int J Mol Sci},
doi = {10.3390/ijms27177611},
url = {https://doi.org/10.3390/ijms27177611}
}RIS
TY - JOUR TI - Selective PPARα Modulator Pemafibrate Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through Regulation of Leptin Signaling and Remodeling of Gut Microbiota. AU - Yamamoto K AU - Baba M AU - Kubo A AU - Yamada R AU - Nakamura A AU - Morikawa K AU - Ohara M AU - Nakai M AU - Sho T AU - Suda G AU - Ogawa K AU - Furuya K AU - Sakamoto N. PY - 2026 JO - Int J Mol Sci DO - 10.3390/ijms27177611 UR - https://doi.org/10.3390/ijms27177611 ER -
APA
K, Y., M, B., A, K., R, Y., A, N., K, M., M, O., M, N., T, S., G, S., K, O., K, F., & N., S. (2026). Selective PPARα Modulator Pemafibrate Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through Regulation of Leptin Signaling and Remodeling of Gut Microbiota.. Int J Mol Sci. https://doi.org/10.3390/ijms27177611
Source records
- europe-pmc · retrieved 2026-09-26T04:38:04.590Z